Cited in boardrooms, legal proceedings & government briefings since 2017
Medical cannabis sales and registered patients in Croatia, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Croatia data pack.
Medical sales, EUR
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Medical sales | — | — | €680.4k | |||
| Patients | — | — | 1,114 |
Forecasts to 2030 — sales, patients and the full Croatia series — are in the Croatia data pack, or scoped to your question in a bespoke brief.
See the data pack Request a briefSource: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)
From International Cannabis Weekly, our free global briefing.
total-croatia-news.com · №240 · 25 Mar 2022 · Health & Science
Ganjapreneur · №135 · 21 Feb 2020 · Adult-use
№134 · 14 Feb 2020 · Regulation
cbdineurope.com · №28 · 18 Jan 2018 · Medical
№28 · 18 Jan 2018 · Medical
cbdineurope.com · №28 · 18 Jan 2018 · Regulation
Croatia legalised the use of medical cannabis on 15 October 2015; however, its implementation has been severely stalled due to bureaucratic barriers, affordability issues, and a lack of engagement from regulators and healthcare professionals.
Treatment is not covered by the public health insurance, so patients must pay the full cost of treatment, paying over €200 monthly. Specialists may prescribe medical cannabis in Croatia to treat the following diseases:
Cancer
AIDS
Multiple sclerosis
Epilepsy
Although Croatia did witness some level of market activity in its early years, with Tilray exporting its liquid capsules in 2016, the market has seen slow to no growth in the following years due to the lack of prescriptions and patients, fueled by high prices and the reluctance of prescribers. There are currently no imports or products available on the market.
In April 2019, the amendments to the Act on Combating Drug Abuse came into force, which legalised the cultivation of medical cannabis. Under the ruling, companies require a special permit from the Ministry of Health and a licence for the production of medicines and active substances from the Agency for Medicinal Products and Medical Devices (HALMED).
